PT-141 (Bremelanotide)

PT-141, also known as Bremelanotide, is a synthetic peptide originally developed from the melanocortin peptide family. It is commonly studied for its role in supporting sexual health and arousal pathways by acting on melanocortin receptors within the central nervous system rather than directly affecting blood vessels like many traditional treatments.

Unlike medications that work primarily through vascular mechanisms, PT-141 is known for targeting neurological pathways associated with sexual desire and response. Because of this mechanism, it has been researched in both men and women for its potential to support healthy libido and sexual function.

Researchers and clinicians have explored PT-141 for its potential to help address conditions related to low sexual desire and arousal, making it a peptide of interest in ongoing studies of reproductive and hormonal health.

Key Characteristics

• Peptide name: PT-141 (Bremelanotide)

• Peptide class: Melanocortin receptor agonist

• Primary area of study: Sexual health and arousal pathways

• Mechanism focus: Central nervous system melanocortin receptors

• Research interest in both male and female libido support

Research Applications

PT-141 has been studied in research environments related to:

• Libido and sexual desire signaling

• Female sexual interest and arousal research

• Male sexual performance support

• Central nervous system melanocortin receptor activity

Format

PT-141 is typically supplied as a lyophilized peptide powder intended for research use and reconstitution in a laboratory setting.

Disclaimer

This product is intended for research and laboratory use only. It is not approved for human consumption, medical treatment, or diagnostic use. All research should be conducted by qualified professionals in controlled environments.